Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Squadrilli, A."'
Autor:
Sacchi, Raffaele, Caporaso, Nicola, Squadrilli, Gian Andrea, Paduano, Antonello, Ambrosino, Maria Luisa, Cavella, Silvana, Genovese, Alessandro
Publikováno v:
In International Journal of Gastronomy and Food Science December 2019 18
Autor:
Chiara Tommasi, Benedetta Pellegrino, Daniela Boggiani, Angelica Sikokis, Maria Michiara, Vera Uliana, Beatrice Bortesi, Francesco Bonatti, Paola Mozzoni, Silvana Pinelli, Anna Squadrilli, Maria Vittoria Viani, Diana Cassi, Giuseppe Maglietta, Marco Meleti, Antonino Musolino
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Women with pathogenic germline mutations in BRCA1 and BRCA2 genes have an increased risk to develop breast and ovarian cancer. There is, however, a high interpersonal variability in the modality and timing of tumor onset in those subjects, thus sugge
Externí odkaz:
https://doaj.org/article/7bcdb9fa7a9a443ca94fd90f33499cc4
Autor:
Silvia La Monica, Roberta Minari, Daniele Cretella, Lisa Flammini, Claudia Fumarola, Mara Bonelli, Andrea Cavazzoni, Graziana Digiacomo, Maricla Galetti, Denise Madeddu, Angela Falco, Costanza Annamaria Lagrasta, Anna Squadrilli, Elisabetta Barocelli, Alessandro Romanel, Federico Quaini, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-12 (2019)
Abstract Background The third generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) osimertinib has been initially approved for T790M positive Non-Small Cell Lung Cancer (NSCLC) and more recently for first-line treatment
Externí odkaz:
https://doaj.org/article/0332689cda2e4440a52ebd48a300166b
Autor:
Filippo G. Dall’Olio, Francesca Abbati, Francesco Facchinetti, Maria Massucci, Barbara Melotti, Anna Squadrilli, Sebastiano Buti, Francesca Formica, Marcello Tiseo, Andrea Ardizzoni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Aims: To assess prognostic value of pre-therapy carcinoembryonic antigen (CEA) and cytokeratin-19 fragments (CYFRA 21-1) blood levels in non-small cell lung cancer (NSCLC) patients treated with immune-checkpoint inhibitors (ICIs) and their early chan
Externí odkaz:
https://doaj.org/article/86efd4aa996242a1bf8707aef0f48a30
Autor:
Giulia Briatico, Camila Scharf, Eugenia Veronica Di Brizzi, Sebastiano Pellerone, Dario Buononato, Francesco Squadrilli, Graziella Babino, Giuseppe Argenziano, Caterina Mariarosaria Giorgio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d88dbd5f056f3f2b64284ea183ccf19
https://hdl.handle.net/11591/490129
https://hdl.handle.net/11591/490129
Autor:
Marika Cinausero, Noemi Laprovitera, Giovanna De Maglio, Lorenzo Gerratana, Mattia Riefolo, Marianna Macerelli, Michelangelo Fiorentino, Elisa Porcellini, Vanessa Buoro, Francesco Gelsomino, Anna Squadrilli, Gianpiero Fasola, Massimo Negrini, Marcello Tiseo, Manuela Ferracin, Andrea Ardizzoni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Programmed cell death 1 (PD-1) and PD-ligand 1 (PD-L1) inhibitors represent novel therapeutic options for advanced non-small cell lung cancer (NSCLC). However, approximately 50% of patients do not benefit from therapy and experience rapid
Externí odkaz:
https://doaj.org/article/bbe74f39c6134ab4a55c01b9a32b30e3
Autor:
Michela Verzè, Roberta Minari, Letizia Gnetti, Paola Bordi, Alessandro Leonetti, Agnese Cosenza, Leonarda Ferri, Maria Majori, Massimo De Filippo, Sebastiano Buti, Donatello Gasparro, Rita Nizzoli, Cinzia Azzoni, Lorena Bottarelli, Anna Squadrilli, Paola Mozzoni, Marcello Tiseo
Publikováno v:
Cancers, Vol 13, Iss 21, p 5403 (2021)
In order to study alternatives at the tissue biopsy to study EGFR status in NSCLC patients, we evaluated three different liquid biopsy platforms (plasma, urine and exhaled breath condensate, EBC). We also reviewed the literature of the cfDNA biologic
Externí odkaz:
https://doaj.org/article/baf6dfbf7bf446ec935f7672e54ef210
Autor:
Giulia Briatico, Camila Scharf, Eugenia Veronica Di Brizzi, Sebastiano Pellerone, Dario Buononato, Francesco Squadrilli, Graziella Babino, Giuseppe Argenziano, Caterina Mariarosaria Giorgio
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 21:291-293
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gabriele Missale, Paola Bordi, Melissa Bersanelli, Federico Quaini, Leonarda Ferri, Giulia Mazzaschi, Andrea Cavazzoni, Pier Giorgio Petronini, Roberta Minari, V. Ferri, C. Mori, Marcello Tiseo, Elena Rapacchi, Alessandro Leonetti, Anna Squadrilli, Sebastiano Buti, Agnese Cosenza, Alessandra Zecca
Publikováno v:
Lung Cancer. 148:1-11
Introduction Upfront criteria to foresee immune checkpoint inhibitors (ICIs) efficacy are far from being identified. Thus, we integrated blood descriptors of pro-inflammatory/immunosuppressive or effective anti-tumor response to non-invasively define